Crossref
EE403 BURDEN OF ILLNESS: DIRECT AND INDIRECT ECONOMIC COSTS OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UNITED STATES
Value in Health · 2026-06 · 29 (6) · S139
DOI: 10.1016/j.jval.2026.03.697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Tiffanie Tran und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tran, T., Sohn, A., Deininger, K. M., Kricorian, G., Qian, J., & Herr, F. (2026). EE403 BURDEN OF ILLNESS: DIRECT AND INDIRECT ECONOMIC COSTS OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UNITED STATES. Value in Health, 29(6), S139. https://doi.org/10.1016/j.jval.2026.03.697
Vancouver
Tran T, Sohn A, Deininger KM, Kricorian G, Qian J, Herr F. EE403 BURDEN OF ILLNESS: DIRECT AND INDIRECT ECONOMIC COSTS OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UNITED STATES. Value in Health. 2026;29(6):S139. doi:10.1016/j.jval.2026.03.697
BibTeX
@article{Tran2026,
author = {Tran, Tiffanie and Sohn, Alexis and Deininger, Kimberly M. and Kricorian, Greg and Qian, Joyce and Herr, Fiona},
title = {EE403 BURDEN OF ILLNESS: DIRECT AND INDIRECT ECONOMIC COSTS OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UNITED STATES},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S139},
doi = {10.1016/j.jval.2026.03.697}
}
EUVIMED